Chalfont St. Giles, UK, 2 May 2017 – Broadening its range of diagnostic options for clinicians and their patients, GE Healthcare announced today that it has received an indication approval from the U.S. Food and Drug Administration (FDA) for its imaging agent Visipaque™ (iodixanol) Injection. Visipaque 320 mg Iodine/mL is an iso-osmolar agent that is... Read more
CHALFONT ST. GILES, UK and HsinCHu, TAIWAN– 25 April 2017 – United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform to its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan. With this added capacity, UBP will support local healthcare needs by bringing... Read more
Chalfont St Giles, UK – 11 April 2017 – GE Healthcare has acquired Asymptote Limited, specialists in cryochain technology for sensitive cellular therapies. Asymptote’s integrated suite of cryochain hardware, software and consumables are designed to maintain the potency of cellular therapies enabling ultra-low temperature freezing during production, all the way to thawing at the clinic... Read more
CHALFONT ST. GILES, UK and CORK, IRELAND – 11 April 2017 – Zenith Technologies and GE Healthcare Life Sciences announce today that GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry. This enhancement of the existing partnership brings... Read more
CHALFONT ST. GILES, UK and Nashville, Tennessee, USA – 3rd April 2017 – GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in Nashville, Tennessee, to provide both low energy (SPECT) and high energy (PET) radiopharmaceuticals to HealthTrust members across the United States. The agreement commenced on March 1, 2017. Marco... Read more
Washington, DC – March 17, 2017 – GE Healthcare (NYSE: GE), introduced CardioGraphe™, the world’s first dedicated cardiovascular computed tomography (CT) system, at the 66th annual meeting of the American College of Cardiology (ACC). CardioGraphe is the result of a strategic partnership between GE Healthcare and Arineta LTD. The two companies established a relationship in 2010... Read more
GE’s Boulder Facility Now is Certified for ISO Guide 34 and ISO/IEC 17025 TREVOSE, PA.—March 28, 2017—Measuring the levels of total organic carbon (TOC) in the water is an important step for pharmaceutical companies to control processes that are critical to their operations and comply with regulations. Today, Analytical Instruments, a division of GE Water... Read more
As part of its ongoing commitment to provide quality healthcare for Egyptians and accelerating solutions to detect cancer early, GE Healthcare today announced that it has supplied Nile Scan & Labs with its exceptional Positron Emission Tomography/ Computed Tomography (PET/CT) molecular imaging system. The new GE Discovery IQ PET/CT comes with advanced early disease detection... Read more
Reusing Rainwater Eliminates the Need to Draw Water from Aquifer Helping Drought-Prone Area Alleviate Water Burden in Winemaking Process Initiative Seeks to Help Create a More Sustainable Wine Industry BOULDER, CO—March 2, 2017—As California’s agriculture industry continues to plan for months of extreme rain followed by months of longer drought, the University of California Davis... Read more
Wauwatosa, Wisconsin – 13 March 2017 – Monitoring expectant mothers and their babies before and during childbirth is a vital and at times a complicated task. GE Healthcare is investing in innovations to make it easier. Today, GE Healthcare announced that it is expanding its Maternal-Infant Care business with the acquisition of Monica Healthcare, a... Read more